Chemcrux Enterprises delivered remarkable financial performance in the June 2026 quarter, with consolidated net profit surging 466.67% to ₹0.51 crore compared to ₹0.09 crore in the corresponding quarter of the previous year. According to reports from Business Standard, this represents one of the most significant profit growth rates in the company's recent financial history. The substantial improvement in profitability demonstrates the company's enhanced operational efficiency and business performance during the quarter.
The company's sales revenue increased 32.97% to ₹21.94 crore in Q1 FY27, up from ₹16.50 crore in the same quarter of the previous fiscal year. As reported by Business Standard, this revenue growth indicates strong demand for the company's products or services, contributing to the overall improvement in financial performance. The significant revenue expansion provides a solid foundation for the exceptional profit growth achieved during the quarter.
The company's operating profit margin (OPM) improved to 12.26% in the June 2026 quarter, compared to 9.88% in the corresponding quarter of the previous year. According to the financial data reported by Business Standard, this margin expansion reflects better cost management and operational efficiency. Additionally, PBDT (Profit Before Depreciation and Tax) increased 79% to ₹2.17 crore from ₹1.21 crore in the previous year, while PBT (Profit Before Tax) rose 3,167% to ₹0.98 crore from ₹0.03 crore in the same quarter last year.
Chemcrux Enterprises shares are currently trading at ₹91.99 as of August 5, 2026, representing an 8.74% decline from the previous close of ₹100.80. The stock has a market capitalization of ₹135.52 crore and has seen a 52-week high of ₹158.60 and 52-week low of ₹64.00. The company's PE ratio stands at 40.09 while the PB ratio is 1.95, reflecting the market's assessment of the company's current valuation.
